These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q3 Results - Vertex Pharmaceuticals (NASDAQ:VRTX)
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported upbeat earnings for its third quarter, while sales missed estimates.
Stay updated with breaking news from Read This. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported upbeat earnings for its third quarter, while sales missed estimates.
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 40 points on Monday The Dow traded up 0.13% to 34,106.99 while the NASDAQ rose 0.16% to 13,499.42. The S&P 500 also rose, gaining, 0.09% to 4,362.35.
U.S. stocks turned lower toward the end of trading, with the Dow Jones falling around 50 points on Monday The Dow traded down 0.16% to 34,007.81 while the NASDAQ fell 0.08% to 13,467.42. The S&P 500 also fell, dropping, 0.13% to 4,352.49.
Give the gift of some self-care to everyone on your holiday shopping list with one (or more!) of these amazing products — details
U.S. stocks traded higher this morning, following the release of jobs report for October. Following the market opening Friday, the Dow traded up 0.50% to 34,009.36 while the NASDAQ rose 1% to 13,427.71. The S&P 500 also rose, gaining, 0.85% to 4,354.30.